Rakovina Therapeutics

Company RKV

Last mentioned: 2d ago

Timeline

Invalid Date
Closing of Private Placement

Expected completion of the $1.0 million common share offering and debenture issuance.
Invalid Date
Operational Milestone

Anticipated use of funds for lead candidate advancement or IND-enabling studies.
Feb 21, 2026
Financing Upsized

Rakovina announces an increase in its funding round to $2.0 million due to investor demand.

Stories mentioning Rakovina Therapeutics 1

Rakovina Therapeutics Upsizes Financing to $2M to Fuel Oncology Pipeline

Rakovina Therapeutics has announced an upsized financing package totaling up to $2.0 million, split between convertible debentures and a private placement. The capital injection is earmarked for near-term operations as the company advances its DNA-damage response (DDR) oncology programs.

2d ago 2 sources